This information was published on 2025-09-05T00:10:12 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2574584 (IR 1868800) |
| (220) |
04 Jul 2025
|
| (300) |
FR, 04 Apr 2025, 5136096
|
| (511) (510) |
Class 5
Pharmaceutical products for prevention and treatment of cardio-metabolic diseases. |
| (540) | INLIABIX |
| (550) | Word |
| (730) |
BIOFARMA
|
Find out more about publications on the About page.